The U.S. Food and Drug Administration has approved an additional single dose of the bivalent COVID vaccines for individuals above the age of 65 and those with immunocompromise at least four months ...

Regulatory authorities in the US are investigating a possible link between the new Pfizer/BioNTech bivalent COVID-19 booster vaccine and strokes in people aged 65 or over, but still recommend the ...

Although the bivalent COVID-19 vaccine conferred moderate protection against symptomatic disease, hybrid immunity provided the strongest protection.

The Phase 1 trial is an open label, dose ranging clinical study designed to evaluate Vaxart’s second-generation oral norovirus vaccine constructs head-to-head against its first-generation constructs.

The temporary monovalent and bivalent booster side effects of vaccination—including chills, fever, headache, pain at the ...

Moderna has reported preliminary clinical results with a bivalent version of its COVID-19 vaccine that combines its original version with another targeting the Beta variant, and seems to offer ...

"Bivalent mRNA booster vaccination in adults aged 65 years or older is an effective and essential tool to reduce their risk of hospitalisation and death due to Covid-19.

KUALA LUMPUR: Malaysia will receive 2.7 million doses of the new generation (bivalent) Covid-19 vaccines as a replacement for the almost expired stock that are being kept by the Health Ministry.

The “bivalent vaccine” will be made available to people who have received two doses of existing vaccines, starting with elderly people and those with underlying health conditions, according to ...

Biomedical Co. Ltd. has described antibody-drug conjugates comprising an antibody covalently bound to a cytotoxic drug through a bivalent olefin linker optionally consisting of an isotope-labeled ...